by Lisa Nadal | Feb 21, 2024 | 2024, Press Releases
More detailsby Lisa Nadal | Feb 20, 2024 | 2024, Press Releases
FIBROSARC (NCT04650984) is a Phase III trial evaluating Onfekafusp alfa (L19TNF, also known as Fibromun) plus doxorubicin versus doxorubicin alone as front-line therapy for patients with advanced or metastatic Soft Tissue Sarcoma An Independent Data and Safety...
Recent Comments